Unlock stock picks and a broker-level newsfeed that powers Wall Street.

LSE - Delayed Quote USD

Nutrien Ltd. (0NHS.L)

Compare
49.40
+1.42
+(2.97%)
At close: April 9 at 7:02:54 PM GMT+1
Loading Chart for 0NHS.L
  • Previous Close 47.97
  • Open 46.48
  • Bid --
  • Ask --
  • Day's Range 46.48 - 49.41
  • 52 Week Range 46.48 - 75.50
  • Volume 281
  • Avg. Volume 1,419
  • Market Cap (intraday) 32.088B
  • Beta (5Y Monthly) 1.10
  • PE Ratio (TTM) 0.06
  • EPS (TTM) 7.77
  • Earnings Date May 7, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Nutrien Ag Solutions, Potash, Nitrogen, and Phosphate. The Nutrien Ag Solutions segment distributes crop nutrients, crop protection products, seeds, and merchandise products; product application, soil and leaf testing, crop scouting, precision agriculture, water, and brokerage agency services; and financing solutions. The Potash segment provides granular and standard potash products. The Nitrogen segment offers ammonia, urea, environmentally smart nitrogen, nitrogen solutions, nitrates, and sulfates. The Phosphate segment provides solid fertilizer, liquid fertilizer, and industrial and feed products. The company was incorporated in 2017 and is headquartered in Saskatoon, Canada.

www.nutrien.com

25,500

Full Time Employees

December 31

Fiscal Year Ends

--

Sector

--

Industry

Recent News: 0NHS.L

View More

Performance Overview: 0NHS.L

Trailing total returns as of 4/10/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

0NHS.L
13.96%
MSCI WORLD (^990100-USD-STRD)
6.11%

1-Year Return

0NHS.L
7.71%
MSCI WORLD (^990100-USD-STRD)
3.01%

3-Year Return

0NHS.L
48.22%
MSCI WORLD (^990100-USD-STRD)
0.00%

5-Year Return

0NHS.L
0.00%
MSCI WORLD (^990100-USD-STRD)
76.65%

Compare To: 0NHS.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0NHS.L

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.69%

  • Return on Assets (ttm)

    3.10%

  • Return on Equity (ttm)

    2.82%

  • Revenue (ttm)

    25.02B

  • Net Income Avi to Common (ttm)

    674M

  • Diluted EPS (ttm)

    7.77

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    853M

  • Total Debt/Equity (mrq)

    52.40%

  • Levered Free Cash Flow (ttm)

    1.36B

Research Analysis: 0NHS.L

View More

Company Insights: 0NHS.L

Research Reports: 0NHS.L

View More

People Also Watch